Search

Your search keyword '"Wong, Kwok"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Wong, Kwok" Remove constraint Author: "Wong, Kwok" Publication Type Conference Materials Remove constraint Publication Type: Conference Materials
84 results on '"Wong, Kwok"'

Search Results

5. Abstract 3223: Overcome LKB1 mutated cancer resistance to anti-PD1 treatment

7. Abstract 4772: Poziotinib overcomes de novo resistance of HER2 exon 20 mutations in NSCLC and other cancers: Preclinical studies and initial clinical testing

11. Abstract 4778: Assessing efficacy of neratinib in HER2-driven lung cancer

13. Abstract 3682: Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer

14. Abstract B27: Improved survival with erdafitinib (JNJ-42756493) and PD-1 blockade mediated by enhancement of anti-tumor immunity in an FGFR2-driven genetically engineered mouse model of lung cancer

15. Abstract A18: Genomic and neoantigen evolution and resistance to immune checkpoint blockade in metastatic renal cell carcinoma

22. Abstract B99: Immune profiling of NSCLC tumors and matching normal lung samples by multicolor flow cytometry

23. Abstract C75: Overcoming KRAS/LKB1 mutant NSCLC resistance to BET bromodomain inhibitors with gemcitabine or Mcl-1 inhibition

26. Abstract 766: Suppression of gefitinib-induced EMT in EGFR mutant NSCLC preferentially selects for acquired T790M

27. Abstract 1471: Establishment, characterization, and clinical correlation of a platform of ovarian patient-derived xenograft (PDX) models

29. Abstract 1355: Functional inactivation of LKB1 increases the production of pro-inflammatory cytokines and governs response to immune modulation

30. Abstract 1110: Functional genomics reveals genetic dependencies in gastric cancer

31. Abstract 968: Co-occurring genomic alterations define major subsets ofKRAS-mutant lung adenocarcinoma (LUAC) with distinct biology and therapeutic vulnerabilities

35. Abstract 968: β-catenin plays an important role in lung tumor development induced by EGFR mutations

41. Abstract LB-399: Chronic inhibition of mutant EGFR in NSCLC leads to EGFR TKI resistance by TGF-β1 mediated epithelial to mesenchymal transition

43. Abstract A177: Cetuximab resistance associated with dimerization‐independence of oncogenic EGFR mutants

44. Abstract B103: Integrative genomic and proteomic analyses identify novel targets forLkb1deficient metastatic lung tumors

Catalog

Books, media, physical & digital resources